Jenny Johnson

Jenny Johnson is Chief Executive Officer of Franklin Templeton. In a career spanning more than 35 years, she has been a driving force behind the company’s transformation into one of the largest global investment managers with $1.7 trillion in assets under management.

Ms. Johnson held leadership roles in all major divisions of the business before becoming CEO in 2020. She has led the evolution of the business in recent years, further diversifying the company’s investment capabilities and solutions for clients. Ms. Johnson was named to Fortune’s “Most Powerful Women” list in 2026, recognizing the world’s most influential business leaders. She has also been named to Forbes’ “World’s 100 Most Powerful Women” list and Barron’s list of the “100 Most Influential Women in US Finance.” The Committee for Economic Development honored Ms. Johnson with a 2024 Distinguished Leadership Award. In 2026, she was named a CNBC Changemaker. A sought-after speaker at industry conferences and global forums, Ms. Johnson frequently shares her perspective on leadership, the evolving investment landscape, technology, innovation and digital assets.

Ms. Johnson serves on the board of directors of Thermo Fisher Scientific, the Investment Company Institute and the Memorial Sloan Kettering Cancer Foundation. She is a member of the International Advisory Panel of the Monetary Authority of Singapore, the Advisory Board on AI in Finance for Luxembourg and the Advisory Group to the Asian Development Bank, and serves on the NYSE Board Advisory Council.

Ms. Johnson earned her B.A. in economics from the University of California at Davis.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.